HELLS and prostate cancer: Notably, HELLS overexpression is associated with progression of squamous cell, oropharyngeal and prostate cancers, with high HELLS levels also found in bladder, retinal, lung and ovarian tumours and HELLS expression a potential biomarker for melanoma metastasis (27,29–31).